Stuart J. Mair
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 7
- Neutropenia and Cancer Infections 3
-
- Biosimilars and Bioanalytical Methods 4
- Co-authors
- Cornelius Florian Waller (3 shared papers)Miguel Hernandez Bronchud (3 shared papers)Lloyd Stevens (3 shared papers)Karthick Vishwanathan (1 shared paper)James Atherton (1 shared paper)Giorgia Rossi (1 shared paper)Shampa Das (1 shared paper)Ian C. T. Nisbet (1 shared paper)
- Journals
- Xenobiotica (4 papers)Drug Metabolism and Pharmacokinetics (2 papers)Blood (2 papers)Frontiers in Pharmacology (2 papers)Annals of Hematology (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Stuart J. Mair
23 papers receiving 397 citations
Peers
Comparison fields: 5 of 71
- Molecular Medicine 40
- Pharmacology 92
- Pharmacology 32
- Endocrinology, Diabetes and Metabolism 54
- Oncology 85
Countries citing papers authored by Stuart J. Mair
This map shows the geographic impact of Stuart J. Mair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Mair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Mair more than expected).
Fields of papers citing papers by Stuart J. Mair
This network shows the impact of papers produced by Stuart J. Mair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Mair. The network helps show where Stuart J. Mair may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart J. Mair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 53 | |
| 2 | 2013 | 50 | |
| 3 | 2014 | 45 | |
| 4 | 2003 | 38 | |
| 5 | 2010 | 36 | |
| 6 | 2010 | 33 | |
| 7 | 2016 | 29 | |
| 8 | 2017 | 24 | |
| 9 | 2015 | 22 | |
| 10 | 2022 | 20 | |
| 11 | 2013 | 19 | |
| 12 | 2019 | 16 | |
| 13 | 2019 | 10 | |
| 14 | 2020 | 10 | |
| 15 | 2018 | 7 | |
| 16 | 2009 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2009 | 1 | |
| 20 | Design and implementation of a multi-part, flexible protocol to assess the tolerability and pharmacodynamic effects of PUR118 in healthy subjects and COPD patients | 2012 | 1 |
About Stuart J. Mair
Stuart J. Mair is a scholar working on Oncology, Immunology, Pharmacology, Molecular Medicine and Anesthesiology and Pain Medicine, having authored 24 papers that have together received 425 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Neutropenia and Cancer Infections (3 papers), Diabetes Treatment and Management (3 papers), Pneumonia and Respiratory Infections (2 papers), Inflammatory mediators and NSAID effects (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Molecular Medicine (40 citations), Pharmacology (92 citations), Pharmacology (32 citations), Endocrinology, Diabetes and Metabolism (54 citations) and Oncology (85 citations). Stuart J. Mair has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Cornelius Florian Waller, Miguel Hernandez Bronchud, Lloyd Stevens, Karthick Vishwanathan, James Atherton, Giorgia Rossi, Shampa Das, Ian C. T. Nisbet, Anshul Gupta and Claudio Giuliano. Their work appears in journals such as Xenobiotica, Drug Metabolism and Pharmacokinetics, Blood, Frontiers in Pharmacology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.